OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting ZDHHC9 potentiates anti-programmed death-ligand 1 immunotherapy of pancreatic cancer by modifying the tumor microenvironment
Zhiqing Lin, Keke Huang, Hui Guo, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114567-114567
Open Access | Times Cited: 16
Zhiqing Lin, Keke Huang, Hui Guo, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114567-114567
Open Access | Times Cited: 16
Showing 16 citing articles:
Mechanisms and functions of protein S-acylation
Francisco S. Mesquita, Laurence Abrami, Maurine E. Linder, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 6, pp. 488-509
Closed Access | Times Cited: 47
Francisco S. Mesquita, Laurence Abrami, Maurine E. Linder, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 6, pp. 488-509
Closed Access | Times Cited: 47
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
Man Wang, Fei Yu, Yuan Zhang
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Man Wang, Fei Yu, Yuan Zhang
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Palmitoylation alters LDHA activity and pancreatic cancer response to chemotherapy
Luojun Chen, Xiaoke Xing, Yue Zhu, et al.
Cancer Letters (2024) Vol. 587, pp. 216696-216696
Closed Access | Times Cited: 11
Luojun Chen, Xiaoke Xing, Yue Zhu, et al.
Cancer Letters (2024) Vol. 587, pp. 216696-216696
Closed Access | Times Cited: 11
Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways
Rong Wang, Shiwei He, Jun Long, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Rong Wang, Shiwei He, Jun Long, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Diverse Roles of Protein Palmitoylation in Cancer Progression, Immunity, Stemness, and Beyond
Mingli Li, Leisi Zhang, Chun‐Wei Chen
Cells (2023) Vol. 12, Iss. 18, pp. 2209-2209
Open Access | Times Cited: 18
Mingli Li, Leisi Zhang, Chun‐Wei Chen
Cells (2023) Vol. 12, Iss. 18, pp. 2209-2209
Open Access | Times Cited: 18
Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity
Zhaoying Zhang, Caiyue Ren, Rong Xiao, et al.
Science Immunology (2024) Vol. 9, Iss. 101
Open Access | Times Cited: 7
Zhaoying Zhang, Caiyue Ren, Rong Xiao, et al.
Science Immunology (2024) Vol. 9, Iss. 101
Open Access | Times Cited: 7
Protein palmitoylation: biological functions, disease, and therapeutic targets
Yue-Wei Qian, Y Zhao, Feng Zhang
MedComm (2025) Vol. 6, Iss. 3
Open Access
Yue-Wei Qian, Y Zhao, Feng Zhang
MedComm (2025) Vol. 6, Iss. 3
Open Access
Advances in targeting protein S-palmitoylation in tumor immunity and therapy
Miaomiao Han, Yuanhao Lv, Yiyang Chen, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Miaomiao Han, Yuanhao Lv, Yiyang Chen, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
ZDHHC9-Mediated PKG1 Affects Osteogenesis by Regulating MAMs in T2DM
Binyang Li, Guiqiu Ma, Houda Gui, et al.
Journal of Dental Research (2025)
Closed Access
Binyang Li, Guiqiu Ma, Houda Gui, et al.
Journal of Dental Research (2025)
Closed Access
ZDHHC9-mediated CD38 palmitoylation stabilizes CD38 expression and promotes pancreatic cancer growth
Hui Guo, Zhiqing Lin, Wang Zhang, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Hui Guo, Zhiqing Lin, Wang Zhang, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
ZDHHC9-mediated Bip/GRP78 S-palmitoylation inhibits unfolded protein response and promotes bladder cancer progression
Weiquan Li, Jingchong Liu, Tiexi Yu, et al.
Cancer Letters (2024) Vol. 598, pp. 217118-217118
Closed Access | Times Cited: 3
Weiquan Li, Jingchong Liu, Tiexi Yu, et al.
Cancer Letters (2024) Vol. 598, pp. 217118-217118
Closed Access | Times Cited: 3
RNA-encapsulating lipid nanoparticles in cancer immunotherapy: From pre-clinical studies to clinical trials
Tiffaney Hsia, Yunching Chen
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 197, pp. 114234-114234
Closed Access | Times Cited: 2
Tiffaney Hsia, Yunching Chen
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 197, pp. 114234-114234
Closed Access | Times Cited: 2
Natural killer cells for pancreatic cancer immunotherapy: Role of nanoparticles
Virender Kumar, Ram I. Mahato
Cancer Letters (2023) Vol. 579, pp. 216462-216462
Closed Access | Times Cited: 4
Virender Kumar, Ram I. Mahato
Cancer Letters (2023) Vol. 579, pp. 216462-216462
Closed Access | Times Cited: 4
S‐acylation of Ca2+ transport proteins in cancer
Sana Kouba, Nicolas Demaurex
Chronic Diseases and Translational Medicine (2024) Vol. 10, Iss. 4, pp. 263-280
Open Access
Sana Kouba, Nicolas Demaurex
Chronic Diseases and Translational Medicine (2024) Vol. 10, Iss. 4, pp. 263-280
Open Access
Post-translational modifications in drug resistance
Chenggui Miao, Yu Huang, Cheng Zhang, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101173-101173
Closed Access
Chenggui Miao, Yu Huang, Cheng Zhang, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101173-101173
Closed Access
Recapitulating the potential contribution of protein S-palmitoylation in cancer
Suchi Chaturvedi, Avinash Sonawane
Cancer and Metastasis Reviews (2024) Vol. 44, Iss. 1
Closed Access
Suchi Chaturvedi, Avinash Sonawane
Cancer and Metastasis Reviews (2024) Vol. 44, Iss. 1
Closed Access
